BGM Group (NASDAQ:BGM) Trading Down 20.1% – Here’s What Happened

BGM Group Ltd. (NASDAQ:BGM)’s stock price dropped 20.1% during mid-day trading on Monday . The company traded as low as $0.2560 and last traded at $0.2750. Approximately 626,057 shares were traded during mid-day trading, an increase of 105% from the average daily volume of 306,055 shares. The stock had previously closed at $0.3440.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of BGM Group in a research note on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

BGM Group Trading Up 3.4%

The company has a 50-day moving average price of $0.45 and a two-hundred day moving average price of $3.15.

Hedge Funds Weigh In On BGM Group

Several large investors have recently modified their holdings of the stock. Geode Capital Management LLC purchased a new position in BGM Group during the 2nd quarter valued at $412,000. Marshall Wace LLP purchased a new position in BGM Group during the 2nd quarter valued at $218,000. Finally, Mariner LLC purchased a new position in BGM Group during the 3rd quarter valued at $267,000.

BGM Group Company Profile

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.